Search research articles
Contact Us
Filters
Showing results (81-90 of 167) with videos related to
Page
of 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2017
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)
Michael J Seckl, Christian H Ottensmeier, Michael Cullen, et al.
BMC Proceedings
|
October 24, 2024
Risk stratification in breast screening workshop
Andrew Anderson, Cristina Visintin, Antonis Antoniou, et al.
BMJ (Clinical Research Ed.)
|
May 25, 2026
UK National Screening Committee position statement on evidence required for multicancer detection tests
Sarah Batson, Sian Taylor-Phillips, Anne Mackie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2011
Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer
Jonathan A Ledermann, Allan Hackshaw, Stan Kaye, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)
Martin Forster, Allan Hackshaw, Tommaso De Pas, et al.
BMJ Open
|
November 25, 2016
Study protocol for a randomised controlled trial of brief, habit-based, lifestyle advice for cancer survivors: exploring behavioural outcomes for the Advancing Survivorship Cancer Outcomes Trial (ASCOT)
Rebecca J Beeken, Helen Croker, Maggie Heinrich, et al.
Neuro-Oncology Advances
|
July 10, 2020
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial
Lucy Brazil, Angela L Swampillai, Ka Man Mak, et al.
British Journal of Cancer
|
May 22, 2020
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design
Dimitrios A Koutoukidis, Joanne Land, Allan Hackshaw, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 8, 2016
Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin
Rachel J Watkins, Waraporn Imruetaicharoenchoke, Martin L Read, et al.
Thorax
|
November 25, 2022
Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm<sup>3</sup> minimum size threshold for multidisciplinary team referral
Andrew W Creamer, Carolyn Horst, Jennifer L Dickson, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 167) with videos related to
Sort By:
Page
of 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2017
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)
Michael J Seckl, Christian H Ottensmeier, Michael Cullen, et al.
BMC Proceedings
|
October 24, 2024
Risk stratification in breast screening workshop
Andrew Anderson, Cristina Visintin, Antonis Antoniou, et al.
BMJ (Clinical Research Ed.)
|
May 25, 2026
UK National Screening Committee position statement on evidence required for multicancer detection tests
Sarah Batson, Sian Taylor-Phillips, Anne Mackie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2011
Randomized phase II placebo-controlled trial of maintenance therapy using the oral triple angiokinase inhibitor BIBF 1120 after chemotherapy for relapsed ovarian cancer
Jonathan A Ledermann, Allan Hackshaw, Stan Kaye, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 12, 2018
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3)
Martin Forster, Allan Hackshaw, Tommaso De Pas, et al.
BMJ Open
|
November 25, 2016
Study protocol for a randomised controlled trial of brief, habit-based, lifestyle advice for cancer survivors: exploring behavioural outcomes for the Advancing Survivorship Cancer Outcomes Trial (ASCOT)
Rebecca J Beeken, Helen Croker, Maggie Heinrich, et al.
Neuro-Oncology Advances
|
July 10, 2020
Hydroxychloroquine and short-course radiotherapy in elderly patients with newly diagnosed high-grade glioma: a randomized phase II trial
Lucy Brazil, Angela L Swampillai, Ka Man Mak, et al.
British Journal of Cancer
|
May 22, 2020
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design
Dimitrios A Koutoukidis, Joanne Land, Allan Hackshaw, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 8, 2016
Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin
Rachel J Watkins, Waraporn Imruetaicharoenchoke, Martin L Read, et al.
Thorax
|
November 25, 2022
Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm<sup>3</sup> minimum size threshold for multidisciplinary team referral
Andrew W Creamer, Carolyn Horst, Jennifer L Dickson, et al.
Page
of 17